NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Trial Attribute PI - Include v4.4 

CTRP Data Element

Description of CTRP Data Element

CCSG Column Name

P30 Grant Number

The Cancer Center Support Grant number.

Info

This is the P30 Grant Serial number (such as CAxxxxxx). This is NOT the grant associated with the lead organization of the trial.

GrantNumber

Clinical Research Category

The trial type. The 

Include Page
Trial Attribute Trial Type - Include v4.4
Trial Attribute Trial Type - Include v4.4
For information, refer to Trial Types and Subtypes. The report uses the following abbreviations:

  • INT = Interventional trial 

Note:  Expanded Access studies are currently listed in CTRP under the Interventional trial category.

  • OBS = Observational, non-interventional trial
  • ANC/COR = Ancillary/Correlative non-interventional trial
ClinicalResearchCat

Study Source

The

Include Page
Trial Attribute Study Source DT4 Funding - Include v4.4
Trial Attribute Study Source DT4 Funding - Include v4.4
For information, refer to CTRP Trial Categories, Study Sources. The report uses the following abbreviations:

  • N = National
  • E = Externally Peer-Reviewed
  • I = Institutional
  • D = Industrial 

Trials that are imported as Industrial/Other such as Consortia trials are included in the source category as N, E, I. The Study Source column indicates only the content of the trial, not how the trial is entered.

StudySource

Specific Funding Source

The

Include Page
Trial Attribute DT4 Funding Sponsor Org - Include v4.4
Trial Attribute DT4 Funding Sponsor Org - Include v4.4
 

FundingSource

Primary Site

The

Include Page
Trial Attribute Anatomic Sites - Include v4.4
Trial Attribute Anatomic Sites - Include v4.4
For a list of values, refer to Data Table 4 Anatomic Site Values.

PrimarySite
NCT ID

The

Include Page
Trial Attribute NCT ID - Include v4.4
Trial Attribute NCT ID - Include v4.4

NCTID
NCI ID

The

Include Page
Trial Attribute NCI ID - Include v4.4
Trial Attribute NCI ID - Include v4.4

NCIID

Protocol ID

The lead organization trial ID. The

Include Page
Trial Attribute Lead Org Trial ID - Include v4.4
Trial Attribute Lead Org Trial ID - Include v4.4

ProtocolID
Other Protocol IDs 

Additional IDs assigned to the trial, including the following:

  • CTEP or DCP
  • Unique IDs from other registries
  • NIH grant numbers
  • Protocol numbers assigned by the review board
  • Other IDs
OthProtocolID
Local Trial IDThe unique ID assigned at the Cancer Center level and used at the sites level to identify a trial. For instructions on specifying this information in CTRP, refer to Managing Local Trial IDs.  Note:  Identifier that the Cancer Center has provided which helps them to map the trial from their local CTMS to CTRP. LocalTrialID

Is Multi Institutional?

Include Page
DT4 Multi Institutional - Include 20180214
DT4 Multi Institutional - Include 20180214

IsMultiInst

PI (Principal Investigator) - Last Name, First Name, Middle Initial

The

Include Page
Trial Attribute PI - Include v4.4
Include Page
DT4 PI column description - Include 20180322
DT4 PI column description - Include 20180322

LastName, FirstName, MiddleName

Program Code

The

Include Page
Trial Attribute Program Code - Include v4.4
Trial Attribute Program Code - Include v4.4
Multiple program codes are separated with semicolons. For instructions on specifying this information in CTRP, refer to Managing Program Codes.

ProgCode

Open Date

Earliest Date of any of the following Trial status’The official start date of a trial at your Center determined by 1) the date of activation noted in an official clinical trial activation announcement or 2) date of first patient accrual if the trial in question did not have a formal activation announcement.   This value on CTRP DT4 is determined by the earliest “open” status date at any site associated with the center on the trial.  The following trial statuses reflect an “open” status in CTRP:  Active, Enrolling by Invitation, Available, Temporarily closed Closed to accrual Accrual or Temporarily closed Closed to accrual Accrual and interventionIntervention.

OpenDate

Close Date

Latest Date of the first occurrence of any of the following site recruitment status’ at any of the sites associated with the cancer center on the trial:  Closed to Accrual, Closed to Accrual and Intervention, Complete, Administratively Complete or Withdrawn.  If any of the sites The date the clinical research study closed to accrual. This does not include patient follow-up. If the study is still open, this field will be blank/null on the CTRP-generated DT4 report.  This value on the CTRP-generated DT4 is determined by the latest “closed” date at any site associated with the cancer center on the trial do not have one of the following site recruitment status’ (Closed.  The following statuses reflect a “closed” status in CTRP: Closed to Accrual, Closed to Accrual and Intervention, Complete, Administratively Complete or withdrawn), then do not provide a “Close Date” (null; blank on CTRP DT4 report).  Withdrawn.

CloseDate

Phase

The

Include Page
Trial Attribute Phase - Include v4.4
Trial Attribute Phase - Include v4.4
For details, refer to Trial Phase Value Definitions.

PhasePilot

An indication

Include Page
Trial Attribute Pilot - Include v4.4
Trial Attribute Pilot - Include v4.4

IsPilot

Primary Purpose

The

Include Page
Trial Attribute Primary Purpose - Include v4.4
Trial Attribute Primary Purpose - Include v4.4
The report uses the following abbreviations:

  • Tre = Treatment
  • Pre = Prevention
  • Sup = Supportive Care
  • Scr = Screening
  • Dia = Diagnostic
  • Hsr = Health Services Research
  • Bas = Basic Science
  • Dev = Device Feasibility
  • Oth = Other

For more information about these values, refer to Primary Purpose Value Definitions. For instructions on specifying the primary purpose for a trial, refer to Recording Trial Details.

PrimaryPurpose

Official Title

The

Include Page
Trial Attribute Official Title - Include v4.4
Trial Attribute Official Title - Include v4.4

OfficialTitleEntire StudyThe anticipated (target) number of subjects (accrual) for the entire trial if the specified Cancer Center is the lead organization. A blank field indicates that the specified Cancer Center is not the lead organization.EntireStudyYour Center Total

The participating site (Cancer Center) target accrual. The system displays this value if available in CTRP for the trial. For instructions on specifying this information in CTRP, refer to Managing Targeted Accrual. However, the value should be reported in this column if it is at all available, whether in CTRP or otherwise.

YourCenterTotalCenter Reporting Period

The total number of subjects accrued for the trial for all organizations in the Cancer Center Family with the relationship “Organization” for the time period you selected.

  • If detailed accrual information was reported for the trial, the system calculates accrual within the specified time period (such as 12 months) based on the Subject Registration Date.
  • If summary accrual was reported (such as for Industrial trials), the system calculates accrual for a selected time period as follows: 
    • If a cut-off date is available, the system calculates accrual based on the cut-off date.
    • If a cut-off date is not available, the system uses the accrual registration date as the cut-off date.

The system calculates accrual for a selected time period based on the difference between the last summary accrual reported before the time period and the last summary accrual reported within the time period. If no summary accrual was reported before the time period selected, the system displays the last summary accrual reported within the time period as the accrual count for the time period.

For an example, refer to CTRP Data Table 4 Report Accrual Calculation.

Center12MosCenter to Date

The total number of subjects accrued to date (as of the selected time period end date) for the trial for all organizations in the Cancer Center Family with the relationship “Organization”.

For an example, refer to CTRP Data Table 4 Report Accrual Calculation.

CenterToDateOther Reporting Period

The total number of subjects accrued for the trial for all organizations in the Cancer Center Family with the relationship “Affiliation” for the time period you selected.

  • If detailed accrual information was reported for the trial, the system calculates accrual within the specified time period (such as 12 months) based on the Subject Registration Date.
  • If summary accrual was reported (such as for Industrial trials), the system calculates accrual for a selected time period as follows: 
    • If a cut-off date is available, the system calculates accrual based on the cut-off date.
    • If a cut-off date is not available, the system uses the accrual registration date as the cut-off date.

The system calculates accrual for a selected time period based on the difference between the last summary accrual reported before the time period and the last summary accrual reported within the time period. If no summary accrual was reported before the time period selected, the system displays the last summary accrual reported within the time period as the accrual count for the time period.

Other12MosOther to Date

The total number of subjects accrued to date (as of the selected time period end date) for the trial for all organizations in the Cancer Center Family with the relationship “Affiliation”.

OtherToDateEntire Study Accrual To Date
  • If the Lead Organization, column is populated with a summary of accrual for all participating sites on the trial through the last day of the reporting period (directly and not directly connected to the Lead Organization CTRP Family).
  • If a Participating Site, column is blank.
Entire Study Accrual To DateComments

In the CTRP reporting application, this column is intentionally blank. To use this column:

  1. Export the report to Microsoft Excel. For instructions, refer to Working with CTRP Automated Reports.
  2. In the spreadsheet, add comments to this column. (NCI recommends up to 50 characters.)
  3. Print the spreadsheet to PDF.
Comments